NRXS

NeurAxis, Inc. · AMEX

Sector Health Technology
Industry Medical Specialties
Website neuraxis.com
Employees(FY) 17
ISIN US64134X2018

Performance

+0.95%

+5.63%

+0.31%

+4.93%

+19.48%

YTD

+36.32%

Profile

NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Advanced Technical Analysis

Technical Analysis of NRXS 2024-11-20

The stock exhibits a strong bullish sentiment with a Moving Average Score of 90, indicating robust upward momentum, while the Technical Score of 68 further supports this positive outlook. However, the Oscillators Score of 46 suggests a neutral stance, indicating potential consolidation or a pause in the upward trend, which investors should monit...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of NRXS

Stock Rank

Recent News & Updates

2024-11-11 19:10
NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues(Globenewswire)
2024-11-04 20:00
NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024(Globenewswire)
2024-11-03 20:00
NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market(Globenewswire)
2024-10-28 21:00
NeurAxis Announces Capital Blue Cross Medical Policy Coverage for PENFS, effective October 1st 2024(Globenewswire)
2024-10-21 21:00
NeurAxis Announces New CPT Category I Code for Percutaneous Electrical Nerve Field Stimulation(Globenewswire)
2024-09-18 21:00
NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024(Globenewswire)
2024-08-26 21:00
NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024(Globenewswire)
2024-08-12 21:00
NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024(Globenewswire)
2024-08-08 20:00
NeurAxis Reports Second Quarter 2024 Financial Results(Globenewswire)
2024-08-04 21:00
NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday, August 9, 2024(Globenewswire)
2024-06-06 21:00
NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure(Globenewswire)
2024-05-21 20:00
NeurAxis Reports First Quarter 2024 Financial Results(Globenewswire)
2024-05-20 21:00
NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024(Globenewswire)
2024-05-15 21:00
NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida(Globenewswire)
2024-05-15 04:30
NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024(Globenewswire)
2024-04-22 21:00
NeurAxis Announces New Medical Policy Coverage in North Dakota(Globenewswire)
2024-04-11 20:44
NeurAxis, Inc. (NASDAQ:NRXS) Q4 2023 Earnings Call Transcript(Yahoo Finance)
2024-04-09 04:05
NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results(Globenewswire)
2024-04-01 04:15
NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024(Globenewswire)
2024-03-26 21:00
NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry(Globenewswire)
2024-03-10 21:00
NeurAxis Announces Highmark BCBS Policy Coverage(Yahoo Finance)
2024-03-03 20:00
NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage(Yahoo Finance)
2024-02-26 22:00
NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference(Yahoo Finance)
2024-01-30 20:00
NeurAxis Appoints Timothy Henrichs as Chief Financial Officer(Yahoo Finance)
2023-12-19 20:00
NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer(Yahoo Finance)
2023-11-20 04:30
NeurAxis Reports Third Quarter 2023 Financial Results(Yahoo Finance)
2023-11-14 20:00
NeurAxis Announces CareFirst BCBS Policy Coverage(Yahoo Finance)
2023-11-13 20:00
NeurAxis Secures $3 Million Financing(Yahoo Finance)
2023-11-07 20:00
NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device(Yahoo Finance)
2023-09-25 21:00
NeurAxis Announces Results of Comparative Study of IB-Stim and Standard Medical Therapy in Adolescents with Functional Abdominal Pain Disorders(Yahoo Finance)

Page 1 of 2

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.